Clinical trial
A Study of the Efficacy and Safety of Topiramate Treatment in Patients With…
NCT00266591 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00266591 |
|---|---|
| Title | A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy |
| Official title | Single Center TOPAMAX (Topiramate) Monotherapy Trial in Subjects With Refractory Partial Onset Seizures |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Seizures |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 51 |
| Start date | Oct 1, 1992 |
| Completion | Apr 1, 1997 |
| First posted | Dec 19, 2005 |
| Last update posted | Jun 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: